Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

山 東 威 高 集 團 醫 用 高 分 子 製 品 股 份 有 限 公 司 Shandong Weigao Group Medical Polymer Company Limited *

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1066)

NOTICE OF ANNUAL GENERAL MEETING

NOTICE IS HEREBY GIVEN that the annual general meeting (the "AGM") of Shandong Weigao Group Medical Polymer Company Limited*( 山東威高集團醫用高分子製品股份 有限公司)(the "Company") will be held at 2/F, 18 Xingshan Road, Torch Hi-tech Science Park, Weihai, Shandong Province, the PRC at 9:00 a.m. on Monday, 12 June 2017 to consider and, if though fit, pass the following resolutions:

ORDINARY RESOLUTIONS
  1. To consider and approve the audited consolidated financial statements of the Group (including the Company and its subsidiaries) for the year ended 31 December 2016;

  2. To consider and approve the report of the board of directors of the Company (the "Board") for the year ended 31 December 2016;

  3. To consider and approve the report of the Supervisory Committee of the Company for the year ended 31 December 2016;

  4. To declare a final dividend of RMB0.046 per share of RMB0.1 each in the Company for the year ended 31 December 2016;

    * For identification purpose only

  5. To consider and approve the proposal for the re-appointment of Deloitte Touche Tohmatsu as the auditor of the Company for the year ending 31 December 2017, and to authorise the Board to determine his remuneration;

  6. To consider and authorise the Board to approve the remuneration of the directors, supervisors and senior management of the Company for the year ending 31 December 2017;

  7. To re-elect Zhang Hua Wei as an executive director of the Company;

  8. To re-elect Mr. Wang Yi as an executive director of the Company;

  9. To re-elect Mrs. Zhou Shu Hua as an non-executive director of the Company;

  10. To re-elect Mrs. Bi Dong Mei as a supervisor of the Company; and

  11. To re-elect Ms. Chen Xiao Yun as a supervisor of the Company.

    SPECIAL RESOLUTIONS
  12. To consider and, if thought fit, pass the following resolution: THAT:

    1. the Board be and is hereby granted an unconditional general mandate to issue, allot and/or deal with additional shares in the capital of the Company (whether Non- listed Shares or H Shares) and to make or grant offers, agreements and options in respect thereof, subject to the following conditions:

      1. such mandate shall not extend beyond the Relevant Period save that the Board may during the Relevant Period make or grant offers, agreements or options which might require the exercise of such powers after the end of the Relevant Period;

      2. the aggregate nominal amount of shares allotted or agreed conditionally or unconditionally to be allotted (whether pursuant to an option or otherwise) by the Board shall not exceed:

        1. 20% of the aggregate nominal amount of the Non-listed Shares in issue; and/or

        2. 20% of the aggregate nominal amount of the H Shares in issue; in each case as at the date of the passing of this resolution; and

        3. the Board will only exercise its power under such mandate in accordance with the PRC Company Law and the Listing Rules or other applicable laws, rules and regulations of other government or regulatory bodies and only if all necessary approvals from the China Securities Regulatory Commission and/or other relevant PRC government authorities are obtained;

        4. contingent on the Board resolving to issue shares pursuant to paragraph (1) of this resolution, the Board be and is hereby authorized:

          1. to approve, execute and do or procure to be executed and done all such documents, deeds and things as it may consider necessary in connection with the issue of such new shares of the Company, including, without limitation, determining the time and place of issue, making all necessary applications to the relevant authorities, and entering into underwriting agreement(s) (or any other agreements);

          2. to determine the use of proceeds and to make necessary filings and registration with the PRC, Hong Kong and other relevant authorities; and

          3. to make such amendments to the articles of association of the Company as it may deem appropriate for the increase of the registered capital of the Company and to reflect the new share capital structure of the Company under the intended allotment and issue of the shares of the Company pursuant to the resolution under paragraph (1) of this resolution.

          4. For the purposes of this resolution:

            "Non-listed Shares" means the non-listed shares in the share capital of the Company with a nominal value of RMB0.10 each, which are held in Renminbi;

            "Listing Rules" means the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (as the same may be amended from time to time);

            "H Shares" means the overseas-listed foreign invested shares in the share capital of the Company with a nominal value of RMB0.10 each, which are held and traded in Hong Kong dollars;

            "Hong Kong" means the Hong Kong Special Administrative Region of the PRC;

            "PRC" means the People's Republic of China, excluding, for the purpose of this resolution only, Hong Kong, the Macau Special Administrative Region of the PRC and Taiwan;

            "Relevant Period" means the period from the date of passing this resolution until whichever is the earliest of:

            1. the conclusion of the next annual general meeting of the Company following the passing of this resolution; or

            2. the expiry date of the 12-month period following the passing of this resolution; or

            3. the date on which the authority granted to the Board set out in this resolution is revoked or varied by a special resolution of the shareholders of the Company in a general meeting.

            "RMB" means Renminbi, the lawful currency of the PRC.

          Shandong Weigao Group Medical Polymer Co. Ltd. published this content on 19 April 2017 and is solely responsible for the information contained herein.
          Distributed by Public, unedited and unaltered, on 21 April 2017 14:18:18 UTC.

          Original documenthttp://114.215.64.52/upload/pdf/model_1492670820.pdf

          Public permalinkhttp://www.publicnow.com/view/E14F1811BC9BE45F8296F4513B1EE5A7236F8B48